OGEN

Oragenics, Inc. is a biotechnology company based in Tampa, Florida, focused on the development of innovative antibiotics and therapies for infectious diseases, including those caused by antibiotic-resistant bacteria. The company is actively pursuing novel drug candidates that leverage its proprietary technologies to address critical healthcare challenges. With a commitment to advancing healthcare solutions, Oragenics aims to contribute significantly to the global fight against infections, targeting both treatment and prevention. Through strategic partnerships and research initiatives, the company is positioned to enhance its pipeline and support public health needs in an evolving pharmaceutical landscape.